VanEck Biotech ETF Rating $165.45 +0.82 (+0.50%) Closing price 02/21/2025 03:58 PM EasternExtended Trading$164.99 -0.46 (-0.28%) As of 02/21/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.67Holdings in BBH have an aggregate rating of Moderate Buy based on 482 analyst ratings issued in the past year covering 24 companies (97.8% of the portfolio).BBH Aggregate Price Target$165.45High Prediction$165.45Average Prediction$165.45Low Prediction$165.45Holdings in BBH have an aggregate price target of $165.45 and a range of $165.45 to $165.45 covering 24 companies (97.8% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.79%AMGNAmgen$303.01+1.7%4.4751 of 5 stars2.46$314.09 3.7%24Insider TradePositive News11.73%GILDGilead Sciences$109.95-0.1%4.7947 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News11.68%VRTXVertex Pharmaceuticals$484.24+0.8%4.1169 of 5 stars2.65$505.61 4.4%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News6.34%REGNRegeneron Pharmaceuticals$700.33+0.6%4.6674 of 5 stars2.76$973.13 39.0%25Dividend Announcement5.39%ARGXargenx$644.48-0.5%2.5007 of 5 stars2.86$658.39 2.2%22News CoveragePositive News4.71%IQVIQVIA$190.94-1.6%4.9241 of 5 stars2.90$251.22 31.6%21Analyst ForecastPositive News4.68%NTRANatera$162.31-3.5%2.5723 of 5 stars3.00$170.94 5.3%16Positive News4.25%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4628 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade3.32%ILMNIllumina$94.20-3.1%4.7855 of 5 stars2.62$159.45 69.3%213.24%ICLRICON Public$201.39-0.2%4.6053 of 5 stars2.87$281.00 39.5%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.05%BIIBBiogen$140.64+2.6%4.7515 of 5 stars2.43$211.85 50.6%30Analyst Forecast2.60%BNTXBioNTech$120.01+1.8%2.39 of 5 stars2.88$142.72 18.9%17Positive NewsGap DownHigh Trading Volume2.32%INSMInsmed$81.06-3.0%4.0523 of 5 stars3.00$91.00 12.3%15Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage2.28%NBIXNeurocrine Biosciences$120.69+3.9%4.9825 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up2.04%TECHBio-Techne$64.92-0.9%4.928 of 5 stars2.50$84.29 29.8%8Analyst DowngradeInsider Trade2.04%SRPTSarepta Therapeutics$106.28-2.0%4.5118 of 5 stars2.87$176.77 66.3%23Upcoming Earnings1.98%MRNAModerna$35.53+5.3%4.7405 of 5 stars2.04$60.63 70.6%23Analyst DowngradeOptions Volume1.67%INCYIncyte$72.05+0.9%4.541 of 5 stars2.35$75.59 4.9%201.63%QGENQiagen$39.52+2.5%4.4342 of 5 stars2.30$47.71 20.7%10Analyst Downgrade1.56%CRLCharles River Laboratories International$163.11+0.5%4.7976 of 5 stars1.88$195.71 20.0%16Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.36%RGENRepligen$158.99-2.3%4.4474 of 5 stars2.62$181.00 13.8%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.31%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9201 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.30%EXASExact Sciences$49.26-0.5%4.6972 of 5 stars2.95$72.06 46.3%19Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.57%CYTKCytokinetics$50.26-1.7%4.1939 of 5 stars2.94$82.00 63.2%18News Coverage This page (NASDAQ:BBH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
